MarkDavidHurwitzMD

Summary

• Mark Hurwitz, M.D., FASTRO, FACRO is Chair/Director of Radiation Medicine for New York Medical College and Westchester Medical Center Health Network. He previously served as the Enterprise Cancer Quality and Safety Officer for the Sidney Kimmel Cancer Center – Jefferson Health. Dr. Hurwitz played a central role in the development of the first national radiation oncology patient safety organization and oversaw achievement of first in the nation recognition of the Thomas Jefferson Department of Radiation Oncology as an NCQA patient-centered specialty practice. He has co-chaired multi-society practice guideline setting committees for use of radionuclides in treatment of prostate cancer and standards for patient consent in radiation oncology. On national and international levels Dr. Hurwitz has directed efforts on advancing translation of biology and technology into clinical practice. He previously served as the 24th President of the Society of Thermal Medicine and is a recipient of the J. Eugene Robinson Award, the highest honor bestowed by the Society for outstanding contributions to the field of hyperthermia. Dr. Hurwitz has led ground breaking trials in thermal oncology including a phase II trial demonstrating benefit of hyperthermia in treatment of locally advanced prostate cancer. He served as PI of an international phase III trial which established benefit to use of magnetic resonance guided focus ultrasound treatment of painful bone metastases. He has served as principal investigator for successfully completed RTOG and CALGB studies for prostate cancer and is the PI of NRG GU002. He has published numerous peer reviewed papers, review articles, and book chapters and serves as an invited speaker at many venues around the world.